Unilab Pharmatech, Ltd.

Johnson & Johnson Consumer Companies, Inc.

Other

United Laboratories, Inc.

Novex Science Pte. Limited

Kennie U Dee

Rita Josefina M Santos

Wendell G Mendoza

Sarah A Calapini

Eulogio C Singh

Donna L Valencia

Susan M Niemiec

Danilo L Lambino

Danilo R Venus

Joyce Bedelia B Santos

Ma Joyce Bedelia B Santos

Gerard A Latoga

The present invention relates to a method for producing extended-release potassium citrate tablet containing camauba wax, wherein the method comprises heating the potassium citrate-carnauba wax mixture to a temperature below the temperature at which carnauba wax liquefies. This invention simplifies the production of extended release potassium citrate wax-matrix tablet.

Method for producing extended-release potassium citrate wax matrix tablet

The present invention relates to a high dose extended-release potassium citrate tablet containing carnauba wax, which contains a first portion of melt- or heat-granulated carnauba wax and potassium citrate; and a second portion of non-granulated potassium citrate. The high dose extended-release potassium citrate tablet of this invention has robust batch-to-batch dissolution and friability; and leads to improved production capacity and reduced production cost.

High dose extended-release potassium citrate wax matrix tablet

An aqueous pharmaceutical suspension for oral administration of a drug, which suspension maintains its content uniformity for prolonged period.

Oral suspension formulation

Calcium-fortified acidic beverages that are stable against calcium precipitation when stored for prolonged period at room temperature and elevated temperatures.

Calcium-fortified acidic beverages

A substantially taste masked liquid pharmaceutical composition containing a pharmaceutically effective amount of an unpleasant tasting drug dissolved or dispersed in an aqueous excipient base, said excipient base comprising polyvinyl pyrrolidone and/or copolyvidone, and high molecular weight polyethylene glycol.

Taste masked aqueous liquid pharmaceutical composition

The present invention provides a powdered beverage mix, comprising i) flavor(s), ii) calcium hydroxide, iii) citric and/or malic acid and, iv) a sugar selected from sucrose, fructose, glucose, and combinations thereof, wherein the ratios of acid/sugar and sugar/calcium are selected such that the calcium in the powdered beverage mix dissolves rapidly with very minimal calcium sedimentation when stirred by hand for less than about 60 seconds.

Powered beverage mix with rapidly dissolving calcium

The present invention relates to insect repellant compositions containing, based upon the total weight of the composition, from about 6 to about 30 percent by weight of insect repellant active material having functionality selected from ester, amide, urethane or combinations thereof; from about 5 to about 30 percent by weight of alcohol, and from about 1 to about 10 percent by weight of nonionic surfactant. The compositions of the invention exhibit reduced rates of degradation of the active material in solution and are less drying and irritating to sensitive skin.

Insect repellant compositions

Fatty acid-based compositions which include at least one neutralized fatty acid, a phenol group-containing compound, and a photostable organic ultra-violet absorber are provided. Additionally, a method of preparing such compositions is provided. The method includes neutralizing at least one melted fatty acid; adding an alkanolamine, a phenol group-containing compound, and a photostable organic UV absorber to the neutralized melted fatty acid to form a pourable composition; and cooling the pourable composition.

Growing community of inventors

Quezon, Philippines

Kennie U Dee